Table 3 Genes with large probabilities of hypermethylation or hypomethylation under the axonal guidance pathway in the lung cancer study.
From: Gene-set Analysis with CGI Information for Differential DNA Methylation Profiling
 | Difference in DNAm | Difference in Gene Exp | |||
---|---|---|---|---|---|
 | Mean | SD | Mean | SD | |
Pr(hypermethylation) | |||||
 ABLIM1 | >0.99 | 0.14 | 0.11 | −0.82 | 0.54 |
 DCC | >0.99 | 0.14 | 0.16 | −0.36 | 0.28 |
 EFNA2 | 0.96 | 0.07 | 0.13 | −0.05 | 0.22 |
 EFNB1 | 0.98 | 0.07 | 0.08 | −0.27 | 0.38 |
 EPHA5 | 0.99 | 0.08 | 0.09 | −0.12 | 0.30 |
 EPHA8 | 0.96 | 0.06 | 0.07 | 0.09 | 0.23 |
 LIMK1 | 0.99 | 0.10 | 0.12 | 0.36 | 0.24 |
 LRRC4 | 0.98 | 0.11 | 0.15 | −0.29 | 0.40 |
 NTNG1 | 0.96 | 0.06 | 0.07 | −0.67 | 0.47 |
 PAK2 | >0.99 | 0.13 | 0.13 | −0.08 | 0.47 |
 PAK7 | 0.97 | 0.08 | 0.12 | 0.08 | 0.13 |
 PLXNB1 | 0.99 | 0.13 | 0.17 | <0.01 | 0.13 |
 SEMA3G | 0.99 | 0.09 | 0.08 | −1.72 | 1.35 |
 SEMA3E | 0.91 | 0.04 | 0.08 | −1.22 | 1.47 |
 SLIT2 | 0.93 | 0.05 | 0.10 | −1.62 | 1.11 |
 SLIT3 | 0.93 | 0.06 | 0.13 | −0.44 | 0.38 |
 UNC5A | 0.92 | 0.06 | 0.13 | 0.06 | 0.21 |
 UNC5C | 0.91 | 0.05 | 0.11 | −0.07 | 0.13 |
Pr(hypomethylation) | |||||
 MAPK1 | >0.99 | −0.15 | 0.14 | −0.23 | 0.35 |
 HRAS | 0.97 | −0.07 | 0.06 | −0.04 | 0.41 |
 EPHA1 | 0.98 | −0.07 | 0.08 | 0.24 | 0.21 |
 NFATC2 | 0.91 | −0.05 | 0.05 | −0.19 | 0.39 |
 NGEF | 0.91 | −0.05 | 0.06 | 0.52 | 0.39 |
 NTNG2 | 0.91 | −0.06 | 0.12 | −0.23 | 0.35 |
 PLXNB3 | 0.96 | −0.08 | 0.10 | 0.43 | 0.51 |
 PPP3R2 | 0.98 | −0.10 | 0.12 | <0.01 | 0.11 |
 SEMA3B | 0.97 | −0.10 | 0.15 | −0.60 | 0.43 |
 SEMA4A | 0.98 | −0.16 | 0.19 | <0.01 | 0.61 |
 SEMA4G | 0.93 | −0.05 | 0.06 | 0.25 | 0.51 |
 SEMA6B | 0.98 | −0.10 | 0.11 | −0.06 | 0.41 |